(c) The assurance that pharmaceutical products or medical technologies used to treat pandemics such as HIV/AIDS, tuberculosis and malaria or the most common opportunistic infections that accompany them, irrespective of their sources and countries of origin, are scientifically and medically appropriate and of good quality;
(c) 确保用于治疗艾滋病毒/艾滋病、结核病和疟疾等大流行病或最常见的伴生机会感染的药品或医疗技术，不论来源和原产国为何，在科学上和医学上都是适宜的而且质量优良；